CLOs on the Move

Sight Sciences

www.sightsciences.com

 
Founded in 2011, Sight Sciences develops and commercializes intelligently designed and engineered products that target the underlying causes of the world`s most prevalent eye diseases. The company`s surgical glaucoma product portfolio features the OMNI Surgical System, a dually indicated MIGS device that facilitates the performance of both ab interno trabeculotomy and transluminal viscoelastic delivery. Using proprietary multi-modal functionality, OMNI allows surgeons to target all three sources of resistance in the conventional outflow pathway (trabecular meshwork, Schlemm`s canal and collector channels) with a single device and single corneal incision. The company`s non-surgical dry eye product portfolio consists of the TearCare for ophthalmologists ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Aimee Costa
Associate General Counsel Profile
Steve Tamayo
Vice President/Chief Compliance Officer Profile

Similar Companies

Medtap International

Medtap International is a Bethesda, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MedVenture Technology Corporation

MedVenture Technology dedicates resources to building a strong community. Employees passionate about a charitable organization are encouraged to share their enthusiasm at work. Volunteers are recruited, donations are accepted, and families all around us

Ventec Life Systems

Ventec Life Systems is redefining respiratory care to improve patient outcomes and reduce caregiver challenges in the hospital and home. Ventec`s leading product, VOCSN, seamlessly integrates five separate devices including a ventilator, oxygen concentrator, cough assist, suction, and nebulizer into one unified respiratory system.

MediCepts

MediCepts is a Stuart, FL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

StimGuard

StimGuard is a privately held medical device company engaged in the development, manufacture, and pre-commercialization of wirelessly powered, microtechnology neurostimulators, providing patients with a convenient, safe, minimally invasive, and highly cost-effective urological solution that is easily incorporated into their daily lives. StimGuard`s goal is to evolve its patented, cutting-edge platform into the default for neuromodulation, increasing the accessibility for patients worldwide while lowering the economic impact of urology care management.